AbbVie, Investors Reach $17M Deal Over Failed Inversion

By Amy Lee Rosen · June 19, 2019, 8:20 PM EDT

Drugmaker AbbVie Inc. has reached a $16.75 million agreement to settle a claim that it misled investors about the risks of its failed $54 billion merger with Irish pharmaceutical company Shire...

To view the full article, register now.